Kheiron is now part of DeepHealth

In 2024, Kheiron Medical Technologies became part of DeepHealth, a global leader in AI-powered health informatics. DeepHealth is a wholly owned subsidiary of RadNet, Inc., a leading provider of diagnostic imaging in the US. DeepHealth's mission is to empower breakthroughs in care through imaging. The company aims to push the boundaries of what’s possible in healthcare by leveraging advanced AI to enable operational efficiency, clinical confidence, and better delivery of care, while elevating the experience for care teams through human-centered, intuitive technology.

Kheiron was known for its pioneering product, Mia™ (Mammography Intelligent Assessment), a solution that supported radiologists in breast screening decision-making and could be used as an independent reader, a concurrent reader, and as a triage tool. Headquartered in London, United Kingdom, Kheiron was founded in 2016 with a vision to use deep learning and data science to support radiologists in detecting breast cancer earlier and more accurately. DeepHealth builds on and enhances the capabilities of acquired companies, like Kheiron. Find out more about DeepHealth's breast screening solution, SmartMammo™.